An RFX-driven ciliogenic cell state defines ex vivo FGFR-inhibitor sensitivity in colorectal cancer
Lucie Kralickova, Nicola Miglino, Cinzia Esposito, Ramon Pfaendler, Rebekka Wegmann, Pilar Ballesteros-Cuartero, Julien Mena, Federica Panebianco, Laura Amanda Boos, Ulrich Richter, Parisa Rahimzadeh, Tarun Mehra, Viktor Hendrik Koelzer, Salvatore Piscuoglio, Andreas N. WICKI, Berend Snijder
The paper identifies an RFX-driven ciliogenic cell state in colorectal cancer that is sensitive to FGFR inhibitors and associated with poor prognosis.
bioRxiv · Oct 13, 2026 · PreprintCancer Biology